Please assess the completion status of the following clinical trial:

Trial Title: 68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a diagnosis of IPF and NSIP, based on the American Thoracic Society/European Respiratory Society Consensus Conference~* age ≥ 18 years~* males/females~* signed informed consent~Exclusion Criteria:~* pregnancy~* breast feeding~* healthy volunteers~* paediatric cases~* patients in emergency situations~* patients legally incompetent~* patients who refuse to sign the informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 68Ga-DOTANOC PET/CT in patients with IPF and NSIP (Type: OTHER): one arm study: all patients were studied by 68Ga-DOTANOC PET/CT

Based on this trial design, predict the completion outcome and termination type (if applicable).